Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
1 day ago•Economic Times
1 day ago•Economic Times
1 day ago•Economic Times
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 21, 2024, titled "CuraTeQ Biologics receives approval for oncology biosimilar Bevqolva from UK s MHRA". | Download
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 21, 2024, titled "CuraTeQ Biologics receives approval for oncology biosimilar Bevqolva from UK s MHRA". | Download
Interim 2 • Div/Share: ₹ 1.5